EUVIMEDEUVIMED entdecken
Open Access

Virus-induced APOBEC3 transmutagenesis in bladder cancer initiation

George H Hatton iD, Sally R James iD, Andrew S Mason iD, Richard T Gawne iD, Helena Vogel iD, Karen Hogg iD, Parisa Boukani iD, Gemma Swinscoe iD, Anjum Khan iD, Matthew Welberry Smith iD, Michael A Carpenter iD, Omar Masood iD und 6 weitere

Science Advances · 05.12.2025 · 11 (49)

DOI: 10.1126/sciadv.aea6124 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, erschienen am 05.12.2025. Verfasst von George H Hatton und 17 weiteren Autor:innen. Beteiligte Einrichtung: Jack Birch Unit for Molecular Carcinogenesis, Department of Biology and York Biomedical Research Institute, University of York, Heslington, York, UK. Hauptthemen laut MEDLINE: BK Virus, Cytidine Deaminase, Mutation, Polyomavirus Infections. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, National Cancer Institute, Cancer Prevention and Research Institute of Texas.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Carcinogenesis in human urothelium is driven by a high burden of mutations caused by the antiviral “APOBEC3” (apolipoprotein B mRNA editing enzyme, catalytic subunit–like 3) cytosine deaminase enzymes; however, there is no established viral etiology. BK polyomavirus (BKPyV) is a ubiquitous childhood infection that persists in the kidney during adulthood and is frequently detected in urine. Chronic BKPyV infections of normal human urothelium induced an innate response, including apical extrusion of infected cells. Local paracrine interferon signaling induced APOBEC3 expression in both infected and juxtaposed bystander cells, leading to acquisition of hallmark APOBEC3-mediated mutational signatures that recapitulated the variation in mutational character found in patients with muscle-invasive bladder cancer. In our model for urothelial carcinogenesis, uninfected bystander cells witnessing BKPyV infection become APOBEC3 damaged, escape extrusion, and acquire hypermutable advantage. “Transmutagenesis” explains how cells proximal to infected neighbors acquire cancer-initiating mutations. This hypothesis for how urothelial cancers can develop as APOBEC3 signature rich, while remaining virus-negative, suggests that a large proportion of urothelial carcinomas may be preventable by antiviral intervention.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BK VirusCytidine DeaminaseMutationPolyomavirus InfectionsTumor Virus InfectionsUrinary Bladder NeoplasmsHumansAPOBEC DeaminasesCarcinogenesisUrothelium

Substanzen

APOBEC DeaminasesAPOBEC3 proteins, humanCytidine Deaminase

Autor:innen und Institutionen

  • Jack Birch Unit for Molecular Carcinogenesis, Department of Biology and York Biomedical Research Institute, University of York, Heslington, York, UK.
  • Bioscience Technology Facility, Department of Biology, University of York, Heslington, York YO10 5DD, UK.
  • Laboratory of Cellular Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Faculty of Biological Sciences, School of Molecular and Cellular Pathology, University of Leeds, Leeds, UK.
  • Department of Haematology, St. James's University Hospital, Leeds, UK.
  • Leeds Institute of Medical Research, University of Leeds, Leeds, UK.

ORCID-Profile: George H Hatton, Sally R James, Andrew S Mason, Richard T Gawne, Helena Vogel, Karen Hogg, Parisa Boukani, Gemma Swinscoe, Anjum Khan, Matthew Welberry Smith, Michael A Carpenter, Omar Masood, Iñigo Martincorena, Andrew Macdonald, Reuben S Harris, Gabriel J Starrett, Jennifer Southgate, Simon C Baker

Förderung

  • NCI NIH HHS
  • National Cancer Institute
  • Cancer Prevention and Research Institute of Texas
  • Kidney Research UK
  • York Against Cancer
  • Medical Research Council UK
  • NIH Comparative Biomedical Scientist Training Program supported by the National Cancer Institute in partnership with Colorado State University
  • NanoSeq method development funding from Biology Department pump-priming support at the University of York

Zitieren

APA

Hatton, G. H., James, S. R., Mason, A. S., Gawne, R. T., Vogel, H., Hogg, K., Boukani, P., Swinscoe, G., Khan, A., Welberry Smith, M., Carpenter, M. A., Masood, O., Martincorena, I., Macdonald, A., Harris, R. S., Starrett, G. J., Southgate, J., & Baker, S. C. (2025). Virus-induced APOBEC3 transmutagenesis in bladder cancer initiation. Science Advances, 11(49). https://doi.org/10.1126/sciadv.aea6124

Vancouver

Hatton GH, James SR, Mason AS, Gawne RT, Vogel H, Hogg K, et al. Virus-induced APOBEC3 transmutagenesis in bladder cancer initiation. Science Advances. 2025;11(49). doi:10.1126/sciadv.aea6124

BibTeX
@article{Hatton2025,
  author = {Hatton, George H and James, Sally R and Mason, Andrew S and Gawne, Richard T and Vogel, Helena and Hogg, Karen and Boukani, Parisa and Swinscoe, Gemma and Khan, Anjum and Welberry Smith, Matthew and Carpenter, Michael A and Masood, Omar and Martincorena, Iñigo and Macdonald, Andrew and Harris, Reuben S and Starrett, Gabriel J and Southgate, Jennifer and Baker, Simon C},
  title = {Virus-induced APOBEC3 transmutagenesis in bladder cancer initiation},
  journal = {Science Advances},
  year = {2025},
  volume = {11},
  number = {49},
  doi = {10.1126/sciadv.aea6124}
}
Kostenlos starten →